BPC-157 was originally derived from a gastric protein and has been shown to protect and repair the digestive lining, reducing symptoms of ulcers and other gastrointestinal issues
This pattern hints at the complex nature of DSIP's role in GH regulation, potentially linking it to sleep-induced GH release, given the peptide's association with slow-wave sleep patterns and the apparent correlation of such sleep phases with GH secretion
Pain Relief: It has also been studied that BPC-157 is helpful for pain relief, offering pain relief for injuries, chronic pain, or post-operative healing
10.1016/s0006-8993(01)02100-x 68 KrebsL
FDA studied it for lipodystrophy
Advantages: Localized delivery to target tissue (skin, scalp) Non-invasive Lower systemic exposure Well-tolerated with established safety record in cosmeceuticals Limitations: Limited dermal penetration (molecular weight ~340 Da near the cutoff for transdermal absorption) No systemic anti-aging or anti-inflammatory effects Efficacy dependent on formulation vehicle (liposomal carriers significantly improve penetration) GHK-Cu Injection (Subcutaneous) GHK-Cu injection is explored in research settings for systemic administration